Submissions

Login or Register to make a submission.

To submit a new paper to our journal:

  1. Register on the Journal website; we encourage you to register also as a Reviewer at the same time;
  2. Follow the Guidelines for Authors for preparation of your manuscript;
  3. Read our Editorial Policies and our Competing Interest policies.
  4. Log in;
  5. Click on the "NEW SUBMISSION" button to start the online procedure.

To submit a revised version:

  1. Log in;
  2. Click on the title of your paper;
  3. Next to the heading "REVISIONS", upload your revised paper by using the "UPLOAD FILE" button;
  4. Inform the Editors that a revised version has been uploaded.

Guidelines for Authors

Manuscripts have to be double-spaced with one-inch margins. Headings must be used to designate the major divisions of the paper. To facilitate the review process, manuscripts should contain page and line numbering. Manuscripts must be written in English. Authors whose native language is not English are strongly advised to have their manuscript checked by a language editing service, or by an English mother-tongue colleague prior to submission.

As an option, we offer its own professional copyediting service. Professional copyediting can help authors improve the presentation of their work and increase its chances of being taken on by a publisher. In case you feel that your manuscript needs a professional English language copyediting checking language grammar and style, you can find a reliable revision service at:

Manuscript preparation

IMPORTANT: As of September 1st, 2020, the Author Guidelines of the Journal of Osseointegration, Periodontics and Prosthodontics have been updated. Please review these updates to ensure your submission complies with the new ethics and study design requirements. If you have any questions, please contact the editorial office: cristina.calchera@ariesdue.it

The components of a manuscript should consist of: title page, conflict-of-interest notification, keywords, structured abstract, body of text, acknowledgements, references, illustrations (including legends) and tables. Manuscripts must be original and written in English. Manuscript texts should be uploaded as Word files.

Title page

The full names and professional/academic affiliations of all authors must be detailed in the specific section of the submission form. Contact details (including phone, fax, and email address) should be provided for the corresponding author.

All authors must have made substantive intellectual contribution to the study, as recommended by the International Commette of Medical Journal Editors, ICMJE. For authorship of multicentric trials, the individuals directly responsible for the manuscript should be identified.

The first page should include:

1. The title of the article (descriptive but concise, including the study design).
2. If the paper was presented at an organized meeting, the name of the organization, location and date of the meeting should be included.
3. Disclaimers, if any.
4. Source(s) of support in the form of grants, equipment, drugs or all of these.
5. Running title of no more than 40 characters (including spaces).
6. A word count for the text (excluding abstract, acknowledgements, figure legends, and references), which should preferably be at least 4,000 words.
7. The number of figures and tables.

Conflict-of-interest notification. A statement of financial or other relationships that might lead to a conflict of interest.

Keywords. 3–5 keywords or short phrases that capture the main topics of the article. Terms from the Medical Subject Headings (MeSH) list of Index Medicus should be used (www.nlm.nih.gov/mesh); if suitable MeSH terms are not yet available for recently introduced denominations, other terms may be used.

Abstract. A maximum 350-word structured abstract (aims, materials and methods, results, conclusions).

Main Text

Introduction. It provides context or background for the study (i.e. the nature of the problem and its significance). State the specific purpose or research objective of, or hypothesis tested by, the study or observation; the research objective is often more sharply focused when stated as a question. Both the main and secondary objectives should be made clear, and any pre-specified subgroup analyses should be described. Give only strictly pertinent references and do not include data or conclusions from the work being reported. Aims of the study and null hypothesis must be clearly stated at the end of the introduction section
Materials and methods. Include only information that was available at the time the plan or protocol for the study was developed. All information obtained during the conduct of the study belongs in the Results section. Describe your selection of observational or experimental participants (patients, including controls) clearly, including eligibility and exclusion criteria and a description of the source population. Identify the methods, apparatus (give the manufacturer’s name, city and country in parentheses) and procedures in sufficient detail to allow other workers to reproduce the results. Give references, if needed, to established methods, including statistical methods (see below); provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s) and route(s) of administration. Describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. Analyze the patient as the unit of statistical analysis or take into account the structure of data, for example implants clustered within patients. When possible, quantify findings and present them with appropriate indicators of measurement, error or uncertainty (such as confidence intervals). Avoid relying solely on statistical hypothesis testing, such as the use of P values, which fails to convey important information about effect size. References for the design of the study and statistical methods should be to standard works when possible (with pages stated). Authors submitting review manuscripts should include a section describing the methods used for locating, selecting, extracting and synthesizing data. These methods should also be summarized in the abstract.
Results. Present your results in a logical sequence in the text, tables and illustrations, giving the most important findings first. Do not repeat in the text all the data in the tables or illustrations. When data are summarized give absolute numbers from which percentages can be calculated, and specify the statistical methods used to analyze them. Restrict tables and figures to those needed to explain and support the argument of the paper. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. Guidelines for reporting statistics results can be found in Lang TA, Secic M. How To Report Statistics in Medicine. Annotated Guidelines for Authors, Editors, and Reviewers. 2nd Edition, Philadelphia: American College of Physicians; 2006.
Discussion. The new and important aspects of the study and the conclusions that follow from them should be emphasized. Do not repeat in detail data or other material given in the Introduction or the Results section. State the limitations of the work, compare your results with other similar relevant studies, and explore the implications of the findings for future research and for clinical practice. State new hypotheses when warranted, but clearly describe them as such.
Conclusion. Link your conclusions with the goals of the study but avoid unqualified statements not adequately supported by the data. State the clinical implications of your findings.
Acknowledgements. Individuals who have made substantive contributions to the study should be acknowledged. Specify any grants or other financial support. If data (i.e. individual patient data) related to a manuscript are not presented in it but are available from the author or other source, or are online, information on how to obtain this material may be given in the Acknowledgements section.
References. Readers should be provided with direct references to key original research sources, whenever possible. All references must be cited in the text, using the Vancouver (numbered references) style. References should be marked in order of appearance with numbers in round brackets, and listed numerically in the reference list at the end of the article.

Journal reference style:

  • Rengo C, Nappo A, Pantaleo G, Spagnuolo G, Ferrari M. Influence of implant dimensions and position on primary and secondary stability: a prospective clinical study in mandible using resonance frequency analysis. J Osseointegr 2020;12(1):34-38. 

Book reference style:

  • Lee JS, Kim JK, Park Y-C, Vanarsdall RL. Applications of Orthodontic Mini Implants. Chicago: Quintessence; 2007.
  • Baumgartner JC. Pulpal infections including caries. In: Hargreaves KM, Goodis HE (eds). Seltzer and Bender‘s Dental Pulp. Chicago: Quintessence; 2002. P 281-307.

Avoid citing a ‘personal communication’ unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text. Authors should obtain written permission and confirmation of accuracy from the source of a personal communication. Provide complete information for each reference. If the reference is part of a book, also include the title of the chapter and name(s) of the book’s editor(s). Reference to electronic documents that can be found on the Internet should be accompanied with their URL, and the date of last access.

Illustrations (including legends). Illustrations (graphs, photographs and radiographs) must be numbered and cited in the text in order of appearance and submitted electronically in any format (tif, gif, jpg, psd, eps, etc.) that can be opened using Adobe Photoshop(at least 300 dpi). However, tables and figures can be embedded within the Word document.
Legends for illustrations must be on a separate page and should use Arabic numerals corresponding to the illustrations. When symbols, arrows, numbers or letters are used to identify parts of the illustrations, identify and explain each one clearly in the legend. Explain the internal scale and identify the method of staining in photomicrographs.

Tables. Number tables consecutively in the order of their first citation in the text and supply a brief title for each. Do not use internal horizontal or vertical lines. Give each column a short or abbreviated heading. Authors should place explanatory matter in notes, not in the heading. Explain in notes all nonstandard abbreviations, using the following symbols, in sequence: *,†,‡,§,||,¶, **,††,‡‡. Identify statistical measures of variations, such as standard deviation and standard error of the mean. If you use data from another published or unpublished source, obtain permission and acknowledge them fully. This journal strongly encourages authors to make detailed data accessible to other researchers (tables with individual patient data are welcome). Additional tables containing backup data too extensive to publish in print may be appropriate for publication in the electronic version of the journal, deposited with an archival service or made available to readers directly by the authors. In that event an appropriate statement will be added to the text. Submit such tables for consideration with the paper so that they will be available to the peer reviewers.

Abbreviations. Use only standard abbreviations. Avoid abbreviations in the title. The full term for an abbreviation should precede its first use in the text unless it is a standard unit of measurement.

Trade names. Generic terms are to be used whenever possible, but trade names and manufacturers should be included in parentheses when first mentioned.

Units of measurement. The International System of Units (SI) should be used. Measurements of length, height, weight and volume should be reported in metric units (meter, kilogram or liter) or their decimal multiples. Temperatures should be in degrees Celsius. Blood pressures should be in millimeters of mercury.

Submission Instructions

Submission is via the online submission section “Make a submission”, therefore no paper version is required.

Cover letter. Manuscripts must be accompanied by a cover letter, which should include the following details.
I) A statement that the manuscript has been read and approved by all the authors, that the requirements for authorship as stated earlier in this document have been met, and that each author believes that the manuscript represents honest work.
II) If the manuscript has been previously submitted to another journal, it is helpful to include the previous editor’s and reviewers’ comments along with the authors’ responses to those comments. Editors encourage authors to submit these previous communications as doing so may expedite the review process.
III) Copies of any permission to reproduce published material, to use illustrations or report information about identifiable people, or to name people for their contributions must accompany the manuscript.

Review/editing of manuscripts. Manuscript selection is exclusively based on the quality of the individual manuscripts, independent of the identity of the submitting authors, country of origin, brand of the materials used or results. Manuscripts which were not rejected at the initial screening will be peer-reviewed using the online manuscript review and tracking system. The manuscript is sent to two external reviewers by the Editor or Associate Editors. Reviewers may be members of the Editorial Board. Final decisions are made by the Editor-in-Chief or the Editor, based on the reviewer reports and/or the recommendation from the Associate Editor responsible for the manuscript. For papers based on already published articles, the review procedure will be abbreviated: they will be approved for publication by the Editor. Subject to the author’s final approval, the publisher reserves the right to edit accepted manuscripts in the interest of conciseness, clarity and stylistic consistency.

Adherence to guidelines. Manuscripts that are not prepared in accordance with these guidelines may be rejected.

Mandatory submission & copyright form. The submission and copyright form must accompany all submitted manuscripts before they can be reviewed for publication. This form can be downloaded from https://www.pagepressjournals.org/public/License_Agreement.pdf or requested from cristina.calchera@ariesdue.it
All authors should sign the form (separate forms are acceptable), and a scan of the completed form(s) should be uploaded with the submitted manuscript.

Author misconduct. JO editors will have the option at their discretion to request the submitting authors‘ original data including radiographs, pictures, etc., in order to independently verify the manuscript content. Failure to provide the requested information will result in immediate rejection of the manuscript. In addition, authors or co-authors who have published data that have been proven to be falsified will be banned from publishing in JO indefinitely.

Permissions & waivers
• If material has been published, acknowledge the original source and submit written permission from the copyright holder to reproduce the material. Permission is required irrespective of authorship or publisher except for documents in the public domain.
• Written consent from the patient is required to allow publication where a patient is identifiable. A consent form can be https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=3111075_informed_consentf1.jpg. Identifying details should be omitted unless essential.
• Grant support or any other direct or indirect involvement or commercial interest must be declared.
• Authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000.

Reprints The corresponding author will receive the galley proofs of the article as a pdf file. JO is an open access journal, the full text pdf may be downloaded and used for personal purposes, and posted on a personal website or university website, with full acknowledgement of the publication. If reprints are required, the author(s) should order them from the publisher.
Much of the author guidelines are taken from the International Committee of Medical Journal Editors (ICMJE) Uniform Requirements for Manuscripts Submitted to Biomedical Journals. The ICMJE has neither endorsed nor approved the contents of these guidelines, which, as the ICMJE periodically updates the Uniform Requirements, may not accurately represent the current official version, available at http://www.ICMJE.org/.

 

Peer-review policy

All manuscripts submitted to our journal are critically assessed by external and/or in-house experts in accordance with the principles of peer review (http://www.icmje.org/#peer), which is fundamental to the scientific publication process and the dissemination of sound science. Each paper is first assigned by the Editors to an appropriate Associate Editor who has knowledge of the field discussed in the manuscript. The first step of manuscript selection takes place entirely in-house and has two major objectives: i) to establish the article appropriateness for our journals readership; ii) to define the manuscript priority ranking relative to other manuscripts under consideration, since the number of papers that the journal receives is much greater than it can publish. If a manuscript does not receive a sufficiently high priority score to warrant publication, the editors will proceed to a quick rejection. The remaining articles are reviewed by at least two different external referees (second step or classical peer review). Manuscripts should be prepared according to the Uniform Requirements established by the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org/#prepare).

Authorship
All persons designated as authors should qualify for authorship according to the ICMJE criteria (http://www.icmje.org/ethical_1author.html). Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should only be based on substantial contributions to i) conception and design, or analysis and interpretation of data; and to ii) drafting the article or revising it critically for important intellectual content; and on iii) final approval of the version to be published. These three conditions must all be met. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Any part of an article critical to its main conclusions must be the responsibility of at least one author. Authors should provide a brief description of their individual contributions.

Obligation to Register Clinical Trials (http://www.icmje.org/#clin_trials)
The ICMJE believes that it is important to foster a comprehensive, publicly available database of clinical trials. The ICMJE defines a clinical trial as any research project that prospectively assigns human subjects to intervention or concurrent comparison or control groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Medical interventions include drugs, surgical procedures, devices, behavioral treatments, process-of-care changes, etc. Our journals require, as a condition of consideration for publication, registration in a public trials registry. The journal considers a trial for publication only if it has been registered before the enrollment of the first patient. The journal does not advocate one particular registry, but requires authors to register their trial in a registry that meets several criteria. The registry must be accessible to the public at no charge. It must be open to all prospective registrants and managed by a non-profit organization. There must be a mechanism to ensure the validity of the registration data, and the registry should be electronically searchable. An acceptable registry must include a minimum of data elements (http://www.icmje.org/#clin_trials). For example, ClinicalTrials.gov (http://www.clinicaltrials.gov), sponsored by the United States National Library of Medicine, meets these requirements.

Protection of Human Subjects and Animals in Research
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2013 (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should indicate whether institutional and national standards for the care and use of laboratory animals were followed. Further guidance on animal research ethics is available from the World Medical Association (2016 revision, https://www.wma.net/policies-post/wma-statement-on-animal-use-in-biomedical-research) and from the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare (http://www.veteditors.org/consensus-author-guidelines-on-animal-ethics-and-welfare-for-editors). When reporting experiments on ecosystems involving non-native species, Authors are bound to ensure compliance with the institutional and national guide for the preservation of native biodiversity.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor). While the manuscript is undergoing the peer review phase, the authors will not submit the manuscript to another journal without notifying the editor.
  • The submission file is in Microsoft Word or PDF document file format.
  • We fight plagiarism: please understand that your article will be checked with available tools for discovering plagiarism.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  • Please read this advice and download all associated files. The International Committee of Medical Journal Editors has recently published in all ICMJE journals an editorial introducing a new Disclosure Form for Potential Conflict of Interest, with the aim to establish uniform reporting system, which can go over the existing differences in current formats or editor requests. We at Ariesdue welcome this initiative as a possible uniforming, standardizing way to have this important disclosure authorizing the publications of manuscripts. We are therefore asking you to duly fill in the Uniform Format for Disclosure of Competing Interests in ICMJE Journals and upload it on the Web site of the journal your work is involved with or email it back to us, in mind to allow Ariesdue to peer-reviewing your work. The document is in Adobe format, it includes instructions to help authors provide the requested information and the completion procedure is user-friendly. Kindly note that the format have to be completed and signed by each author of the work. We remain waiting for the completed form to proceed with publication. Please be informed that if this Disclosure Form is missing, we will not be able to publish your work.

Privacy Statement

Introduction

In accordance with European Union guidelines General Data Protection Regulation (GDPR), users may decline to provide the information requested. They should be advised, however, that PAGEPress may be unable to deliver its services unless at least the information necessary for security and identification purposes is provided. In order to offer the best possible service to users, we  tracks the patterns of usage of pages on our sites. This enables us to identify the most popular articles and services. Where users have provided details of their research areas of interest, this information can be correlated, helping PAGEPress to provide a useful service for scientists, offering them the most relevant information based on their areas of interest. User information will only be shared with third parties with the explicit consent of the user.  
Publishing a scientific manuscript is inherently a public (as opposed to anonymous) process. The name and e-mail address of all authors of a manuscript published and/or submitted will be available to users of PAGEPress. These details are made available in this way purely to facilitate scientific communication. Collecting these e-mail addresses for commercial use is not allowed, nor will PAGEPress itself send unsolicited e-mail to authors, unless it directly concerns the paper they have published on any PAGEPress journals.
We will only use the personal data gathered over this website as set out in this policy. Below you will find information on how we use your personal data, for which purposes your personal data is used, with whom it is shared and what control and information rights you may have.

Protecting users' personal information
Our journals’ sites use cookies to help provide you with the best viewing experience: some aspects of our services published on our website do require the use of cookies, and the supply of information such as name, e-mail address etc. This is necessary for security reasons and also for us to be able to assure standards of scientific integrity. Users may submit further personal information (e.g. details of research areas of interest) in order to take advantage of present and future personalization facilities on our website.
PAGEPress Publications process personal data from our members, participants, grantees and other contact persons, in order to provide our services in the best way possible. This statement explains how and why we are processing personal data. This privacy statement relates to all our processes involving personal data.

Our processing activities
We publish scholarly journals, proceedings, news and data. This material is freely available. The following summary offers a quick overview of the data processing activities that are undertaken on our website. You will find more detailed information under the indicated sections below.

  • When you visit our website for informational reasons without setting up an account, only limited personal data will be processed to provide you with the website itself.
  • If you are identified as belonging to a customer organisation then we collect information in order to be able to provide usage reporting to that customer.
  • In case you register for one our services or subscribe to our article alerts or newsletters, further personal data will be processed in the scope of such services.
  • Furthermore, your personal data will be used to provide you with relevant advertising for our services and products and for statistical analysis that helps us to improve our website. Additionally, we improve your website experience with third party content.
  • Your personal data may be disclosed to third parties that might be located outside your country of residence; potentially, different data protection standards may apply.
  • We have implemented appropriate safeguards to secure your personal data and retain your personal data only as long as necessary.
  • Under the legislation applicable to you, you may be entitled to exercise certain rights with regard to the processing of your personal data.

Definitions
Personal data: means any information relating to a natural person who can be identified, directly or indirectly, in particular by reference to an identifier such as a name, an identification number, location data, or an online identifier.
Processing: means any operation which is performed on personal data, such as collection, recording, organisation, structuring,storage, adaptation or any kind of disclosure or other use.

Informational use of the website
When you visit our website for informational reasons, i.e. without registering for any of our provided services and without providing us with personal data in any other form, we may automatically collect additional information about you which will contain personal data only in limited cases and which is automatically recognised by our server, such as:

  • your IP address
  • your device type, name and IDs
  • the date and time of your requests
  • the content of your requests
  • information on your browser version
  • your screen resolution
  • information on your operating system, including language settings.

We use such information only to assist us in providing an effective service (e.g. to adapt our website to the needs of your device or to allow you to log in to our website), and to collect broad demographic information for anonymized, aggregated use.

If you are identified by IP or equivalent method as belonging to a customer organisation such as university or a company then we will also collect the identity of that organisation and use it to create usage reports which show the organisation how much of the content we publish is being read by their students, members or employees. This information does not contain anything related to a personal login unless (a) you are a nominated administrator for that organisation or (b) your organisation specifically requires it as a part of a usage-based access contract.
The personal data automatically collected is necessary for us to provide the website, and for our legitimate interest to guarantee the website's stability and security.

Registration for our services
If you need to create a personal login with us then we will store and process the following:

  • Information (such as your name, user name and email address) that is provided by registration
  • Information in connection with an account sign-in facility (e.g. log-in and password details)
  • Communications sent by you (e.g. via e-mail or website communication forms)
  • The information that is necessary for the performance of the service is labelled accordingly. All further information is provided voluntarily.

We will process the personal data you provide to:

  • Identify you at sign-in
  • Provide you with the services and information offered through the website or which you request
  • Administer your account
  • Communicate with you
  • Behavioural Advertising and profiling

You can object to the use of your personal data for direct marketing at any time. We will then refrain from any processing to the extent it is related to such purposes. You may opt-out of direct marketing via opt-out links in any marketing communication or via user profile pages on the website (where available). You can also inform us about your objection by contacting our Data Protection Office at privacy@pagepress.org

We offer notification services such as table-of-contents or new article alerts. This service is provided by means of a double-opt-in. Thus, you will receive an email containing a link by which you can confirm that you are the owner of the email address and wish to be notified via our email service. You can end this service by opting out via the link provided in each notification email. This notification service is based on your consent.
Registration data is kept until such time as an account deletion request is made. If such a request is received we will erase your data within 60 days. Statutory storage obligations or the need for legal actions that may arise from misconduct within the services or payment problems can lead to a longer retention of your personal data. In this case, we will inform you accordingly.

Alerts and Newsletters
With your email address you can subscribe to article alerts and newsletters that provides you with the latest news about our products and services if you consent to receiving such alerts and newsletters. Your email address will be retained as long as you subscribe to our alerts and newsletters.
This service is provided by means of a double-opt-in. Thus, you will receive an email containing a link by which you can confirm that you are the owner of the email address and wish to be notified via our email service. When your subscription is not confirmed, the personal data you provided will not be processed for any purpose. You can unsubscribe from this service by opting out via the link provided in each newsletter.

Analytics

For statistical analyses we use web analytics services such as Google Analytics to collect information about the use of this site.
General tracking information
The tools collect information such as

  • Device and browser information (operating system information, Mobile device identifier, mobile operating system, etc.)
  • IP address
  • Page accessed, URL click stream (the chronological order of our internet sites you visited)
  • Geographic location
  • Time of visit
  • Referring site, application, or service

We use the information we get from the providers only to determine the most useful information you are looking for, and to improve and optimise this website. We do not combine the information collected through the use of the tools with personal data.
Depending on the provider the information generated about your use of the website may be transferred to and processed in third countries, e.g. the United States. For further information about the potential risks of a cross border data transfer please refer to section XII. The tools collect only the IP address assigned to you on the date you visit this site, rather than your name or any other identifying information. The provider will use this information in order to evaluate your use of the website, to compile reports on website activities and to provide other services relating to website and internet use to us.
The legal basis for this processing is Art. 6 sec. 1 sent. 1 lit. f GDPR and represents our legitimate interest to analyse our website's traffic to improve the user's experience and to optimise the website in general.

Google Analytics / Google Tag Manager

We use Google Analytics, a web analytics service provided by Google LLC, 1600 Amphitheatre Parkway, Mountain View, CA 94043, USA ("Google"). On our behalf Google will use the information generated by a cookie for the purpose of evaluating your use of the website, compiling reports on website activity and providing other services relating to website activity and internet activity in connection with the use of the website.
We have activated the IP-anonymisation within the Google Analytics service, and your IP address will be truncated within the area of member states of the European Union or other parties to the Agreement on the European Economic Area. Only in exceptional cases the whole IP address will be first transferred to a Google server in the USA and truncated there. The IP-address your browser conveys within the scope of Google Analytics will not be associated with any other data held by Google.
You may refuse the use of cookies by selecting the appropriate settings on your browser; however please note that if you do this you may not be able to use the full functionality of this website. In addition to that you may prevent the collection of the information generated by the cookie about your use of the website (including you IP address) and the processing of this data by Google if you download and install the browser plug-in available at the following link: http://tools.google.com/dlpage/gaoptout

Third party content and social media plug-ins
Links to third party websites
This website may contain links to third party websites. We are not responsible for the content and the data collection on respective third party websites; please check the privacy policy of respective websites for information of respective websites' data processing activities.

Information sharing
Where personal data is disclosed to the following third parties for the purposes mentioned above the legal basis for the transfer of your personal data is Article 6 sec. 1 sent. 1 lit. b and f GDPR. Some of the recipients may reside outside the EEA. For further information about cross border transfer in general and transfers outside of the EEA see XII.
We may disclose anonymous aggregate statistics about users of the website in order to describe our services to prospective partners, advertisers and other reputable third parties and for other lawful purposes, but these statistics will include no personal data.
We may disclose your personal data to contractors who assist us in providing the services we offer through the website. Such a transfer will be based on data processing agreements. Therefore, our contractors will only use your personal data to the extent necessary to perform their functions and will be contractually bound to process your personal data only on our behalf and in compliance with our requests.
In the event that we undergo re-organisation or are sold to a third party, any personal data we hold about you may be transferred to that re-organised entity or third party in compliance with applicable law.
We may disclose your personal data if legally entitled or required to do so (for example if required by law or by a court order).

Cross border data transfers
Within the scope of our information sharing activities set out above, your personal data may be transferred to other countries (including countries outside the EU) which may have different data protection standards from your country of residence. Please note that data processed in a foreign country may be subject to foreign laws and accessible to foreign governments, courts, law enforcement, and regulatory agencies. However, we will endeavour to take reasonable measures to maintain an adequate level of data protection when sharing your personal data with such countries.
In the case of a transfer outside of the EU, this transfer is safeguarded by privacy the Privacy Shield and EU Model Clauses. You can find further information about the aforementioned safeguards by following this link https://ec.europa.eu/info/law/law-topic/data-protection_en

Security
We have reasonable state of the art security measures in place to protect against the loss, misuse and alteration of personal data under our control. For example, our security and privacy policies are periodically reviewed and enhanced as necessary and only authorised personnel have access to personal data. Whilst we cannot ensure or guarantee that loss, misuse or alteration of information will never occur, we use all reasonable efforts to prevent it.
You should bear in mind that submission of information over the internet is never entirely secure. We cannot guarantee the security of information you submit via our website whilst it is in transit over the internet and any such submission is at your own risk.

Data retention
We strive to keep our processing activities with respect to your personal data as limited as possible. In the absence of specific retention periods set out in this policy, your personal data will be retained only for as long as we need it to fulfil the purpose for which we have collected it and, if applicable, as long as required by statutory retention requirements.

Your rights
Under the legislation applicable to you, you may be entitled to exercise some or all of the following rights:

  1. require (i) information as to whether your personal data is retained and (ii) access to and/or duplicates of your personal data retained, including the purposes of the processing, the categories of personal data concerned, and the data recipients as well as potential retention period;
  2. request rectification, removal or restriction of your personal data, e.g. because (i) it is incomplete or inaccurate, (ii) it is no longer needed for the purposes for which it was collected, or (iii) the consent on which the processing was based has been withdrawn;
  3. refuse to provide and -- without impact to data processing activities that have taken place before such withdrawal -- withdraw your consent to processing of your personal data at any time;
  4. object, on grounds relating to your particular situation, that your personal data shall be subject to a processing. In this case, please provide us with information about your particular situation. After the assessment of the facts presented by you we will either stop processing your personal data or present you our compelling legitimate grounds for an ongoing processing;
  5. take legal actions in relation to any potential breach of your rights regarding the processing of your personal data, as well as to lodge complaints before the competent data protection regulators;
  6. require (i) to receive the personal data concerning you, which you have provided to us, in a structured, commonly used and machine-readable format and (ii) to transmit those data to another controller without hindrance from our side; where technically feasible you shall have the right to have the personal data transmitted directly from us to another controller; and/or
  7. not to be subject to any automated decision making, including profiling (automatic decisions based on data processing by automatic means, for the purpose of assessing several personal aspects) which produce legal effects on you or affects you with similar significance.

You may (i) exercise the rights referred to above or (ii) pose any questions or (iii) make any complaints regarding our data processing by contacting us using the contact details set out below.

Amendments to this policy
We reserve the right to change this policy from time to time by updating our website respectively. Please visit the website regularly and check our respective current privacy policy. This policy was last updated on 16/05/2018.
For any questions on how we protect your personal data, you can always contact us by e-mail privacy@pagepress.org

The Italian version of this document is available here.